BCM
BSX icon

Brasada Capital Management’s Boston Scientific BSX Stock Holding History

Brasada Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
61,699
-14,609
-19% -$793K 0.47% 63
2026
Q1 		$4.78M Sell
76,308
-7,953
-9% -$636K 0.88% 47
2025
Q4 		$7.98M Sell
84,261
-3,235
-4% -$317K 1.35% 17
2025
Q3 		$8.43M Sell
87,496
-2,621
-3% -$271K 1.42% 17
2025
Q2 		$9.43M Buy
90,117
+252
+0.3% +$25.5K 1.6% 17
2025
Q1 		$8.23M Sell
89,865
-5,412
-6% -$545K 1.64% 19
2024
Q4 		$8.96M Sell
95,277
-786
-0.8% -$69.2K 1.57% 18
2024
Q3 		$8.11M Sell
96,063
-4,714
-5% -$372K 1.42% 23
2024
Q2 		$7.75M Sell
100,777
-1,208
-1% -$88.4K 1.35% 24
2024
Q1 		$6.98M Buy
101,985
+722
+0.7% +$46.4K 1.23% 23
2023
Q4 		$5.85M Buy
101,263
+10,986
+12% +$586K 1.13% 26
2023
Q3 		$4.74M Sell
90,277
-1,365
-1% -$71.6K 1.11% 26
2023
Q2 		$4.96M Buy
91,642
+71,642
+358% +$3.74M 1.07% 28
2023
Q1 		$1M Buy
+20,000
New +$943K 0.22% 82
2020
Q4 		– Sell
-12,000
Closed -$459K – 144
2020
Q3 		$459K Buy
+12,000
New +$462K 0.12% 108
2020
Q1 		– Sell
-20,000
Closed -$904K – 120
2019
Q4 		$904K Sell
20,000
-2,000
-9% -$83.7K 0.22% 81
2019
Q3 		$895K Sell
22,000
-500
-2% -$21.2K 0.24% 79
2019
Q2 		$967K Buy
22,500
+7,500
+50% +$288K 0.26% 79
2019
Q1 		$576K Buy
15,000
+2,500
+20% +$95.5K 0.17% 95
2018
Q4 		$442K Buy
+12,500
New +$453K 0.15% 112
2018
Q3 		– Sell
-4,000
Closed -$131K – 378
2018
Q2 		$131K Buy
+4,000
New +$121K 0.04% 181
2018
Q1 		– Sell
-20,000
Closed -$496K – 257
2017
Q4 		$496K Buy
+20,000
New +$552K 0.17% 98

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brasada Capital Management's BSX Position: Q2 2026 in Review

Brasada Capital Management reduced its Boston Scientific (BSX) stake by 19% in Q2 2026, selling an estimated $793K and leaving 61,699 shares worth $2.63M. The position accounts for 0.47% of the portfolio, ranked #63.

Brasada Capital Management first reported a position in BSX in Q4 2017 and has held it in 22 quarters since. The position peaked at $9.43M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Brasada Capital Management held 61,699 shares of Boston Scientific worth $2.63M as of Q2 2026.
  • Brasada Capital Management sold 14,609 Boston Scientific shares in Q2 2026, an estimated $793K.
  • Boston Scientific made up 0.47% of Brasada Capital Management's portfolio in Q2 2026, its #63 holding.
  • Brasada Capital Management first reported a position in Boston Scientific in Q4 2017 and has held it in 22 quarters since.
  • Brasada Capital Management's Boston Scientific position peaked at $9.43M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.